Gritstone bio Inc reports results for the quarter ended in September - Earnings Summary

Gritstone bio

03/11/2022 22:11

* Gritstone bio Inc  GRTS.OQ  reported a quarterly adjusted
loss
of 35 cents​​ per share for the quarter ended in September. The
mean expectation of five analysts for the quarter was for a loss
of 40 cents per share.
    * Revenue rose 15.6% to $3.02 million from a year ago;
analysts
expected $3.61 million. 
    * Gritstone bio Inc's reported EPS for the quarter was a
loss
of 35 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Gritstone bio Inc shares had risen by 11.7% this
quarter and
lost 77.7% so far this year.
    * The company reported a quarterly loss of $29.97 million.
    * Wall Street's median 12-month price target for Gritstone
bio Inc
is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 10:11 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.40          -0.35          Beat
 Jun. 30 2022      -0.40          -0.34          Beat
 Mar. 31 2022      -0.37          -0.34          Beat
 Dec. 31 2021      -0.38          -0.37          Beat